GKI-1

Item no.	CS-0019659-5mg
Manufacturer	ChemScene
Amount	5mg
Category	Oncology By Cell Type Hematology Leukemia Lymphoma Mesothelioma Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	2444764-03-6
Similar products	2444764-03-6
Available
CAS	2444764-03-6
Purity	>98%
MWt	269.73
Formula	C15H12ClN3
Solubility	DMSO : 200 mg/mL (741.48 mM; Need ultrasonic)
Clinical Information	No Development Reported
Pathway	Others
Target	Others
Biological Activity	GKI-1 is a Greatwall (GWL) kinase inhibitor with IC₅₀s of 4.9 and 2.5 uM against hGWL^FL and hGWL-KinDom, respectively. GKI-1 robustly inhibits ROCK1 with an IC₅₀ of 11 uM, but only weakly affected PKA^[1]. IC50 & Target: IC50: 4.9 uM (hGWL^FL), 4.9 uM (hGWL-KinDom)^[1] In Vitro: GKI-1 inhibits full-length human GWL, and shows cellular efficacy^[1]. Treatment of HeLa cells (25 and 50 uM, 0-8.5 hours) with GKI-1 reduces ENSA/ARPP19 phosphorylation levels, resulting in a decrease in mitotic events, mitotic arrest/cell death and cytokinesis failure^[1].
Research Area	Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 12/4/2025

Express Delivery: Save 15 days

Compare

Add to wishlist

Get an offer